Methods for using riboprimers for strand displacement replication of target sequences

• US 7,413,857 B2
• Filed: 11/21/2003
• Issued: 08/19/2008
• Est. Priority Date: 11/21/2002
• Status: Active Grant

• Current Assignee: Illumina Incorporated
• Original Assignee: Epicenter Technologies
• Inventors: Dahl, Gary A., Jendrisak, Jerome J., Radek, Agnes J.
• Primary Examiner(s): Chunduru; Suryaprabha
• Application Number:
  US10/719,168
• Publication Number:
  US 20040180361A1
• Time in Patent Office: 1,733 Days
• Field of Search: 435/6, 435/91.2, 435/91.21, 536/24.33
• US Class Current: 435/6.1
• CPC Class Codes: C12N 15/1096 cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
• CPC Class Codes: C12Q 1/6853 using modified primers or templates
• CPC Class Codes: C12Q 2521/301 Endonuclease
• CPC Class Codes: C12Q 2525/125 incorporating agents resulting in resistance to degradation
• CPC Class Codes: C12Q 2531/119 Strand displacement amplification [SDA]

Abstract

Methods, compositions and kits for amplifying a target sequence by strand displacement replication using strand-displacing primers. The method uses primers that have only ribonucleotides or purine ribonucleotides and at least one 2′-substituted pyrimidine-2′-deoxyribonucleotide.

Claims

1. A method for amplifying a target nucleic acid sequence comprising a target nucleic acid, the method comprising the steps of:

a) hybridizing a riboprimer to a DNA template comprising the target nucleic acid sequence, wherein said riboprimer comprises;

i) only ribonucleotides, or ii) only purine ribonucleotides and only pyrimidine nucleotides, wherein at least one of the pyrimidine nucleotides is a pyrimidine 2′

-deoxyribonucleotide having a non-canonical substituent, which substituent is neither an H nor an OH, on the 2′

-position of the deoxyribose sugar moiety;

b) extending the riboprimer with a DNA polymerase that lacks 5′

-to-3′

exonuclease activity; and

c) cleaving the annealed riboprimer with an RNAse H enzyme such that another riboprimer hybridizes to the template and repeats primer extension, whereby multiple copies of the complementary sequence of the target nucleic acid sequence are produced.

2. The method of claim 1, further comprising, prior to step (b), the step of hybridizing a blocking oligonucleotide to a region of the template that is 5′

with respect to hybridization of the riboprimer to the template.

3. The method of claim 1, wherein the method is conducted under isothermal conditions.

4. The method of claim 1, further comprising the step of:

c) attaching the multiple copies produced in step c) onto a solid substrate to make a microarray of the multiple copies.

5. The method of claim 1, further comprising the step of hybridizing the multiple copies produced in step c) to a microarray of nucleic acid molecules immobilized on a surface of a solid phase.

6. The method of claim 1, wherein step (b) comprises utilization of at least one type of labeled dNTP such that labeled extension products are generated.

7. The method of claim 1, wherein the riboprimer comprises AMP, GMP, 2′

-F-dUMP, and 2′

-F-dCMP.

8. The method of claim 1, wherein a plurality of riboprimers is used.

9. The method of claim 1, wherein the riboprimer comprises only ribonucleotides.

10. The method of claim 1, wherein the 2′

-substituent is selected from the group consisting of a fluorine substituent, an amino substituent, a methoxy substituent, and an azido substituent.

11. The method of claim 1, wherein the riboprimer comprises purine ribonucleotides and pyrimidine 2′

-fluoro-2′

-deoxyribonucleotides.

12. The method of claim 1, wherein the entire sequence of the riboprimer is complementary to the 3′

-end portion of the target sequence.

13. The method of claim 1, wherein the 5′

-end portion of the riboprimer is not complementary to the target nucleic acid sequence.

14. The method of claim 13, wherein the non-complementary 5′

end portion provides a sequence that can be copied by second-strand primer extension using as a template a first-strand cDNA primer extension product made using the riboprimer.

15. The method of claim 13 wherein the target-complementary sequence at the 3′

-end portion of the riboprimer comprises a randomized sequence.

16. The method of claim 2, wherein the blocking oligo comprises a peptide nucleic acid (PNA).

17. The method of claim 1, wherein the DNA polymerase is selected from the group consisting of BST DNA polymerase large fragment (ISOTHERM), SEQUITHERM DNA polymerase (EPICENTRE Technologies), BCABEST DNA polymerase (Takara Shuzo Co.), phi29 DNA polymerase, and Exo-minus Klenow DNA polymerase.

18. The method of claim 1, wherein the RNase H enzyme is a thermostable RNase H.

19. The method of claim 18, wherein said thermostable RNase H is selected from the group consisting of HYBRIDASE thermostable RNase H (EPICENTRE Technologies), Tth RNase H, and Tfl RNase H.

20. The method of claim 1, wherein said RNase H is E. coli RNase H.

21. A method for amplifying a target nucleic acid sequence comprising a target nucleic acid, the method comprising:

a) obtaining a DNA comprising a target nucleic acid sequence;

b) obtaining a riboprimer, the riboprimer comprising;

i) only ribonucleotides, or ii)

only purine ribonucleotides and only pyrimidine nucleotides, wherein at least one of the pyrimidine nucleotides is a pyrimidine 2′

-deoxyribonucleotide having a non-canonical substituent, which substituent is neither an H nor an OH, on the 2′

-position of the deoxyribose sugar moiety, and wherein at least the 3′

-end portion of the riboprimer is complementary to a portion of the target nucleic acid sequence;

c) annealing the riboprimer to the DNA;

d) obtaining a strand-displacing DNA polymerase that lacks 5′

-to-3′

exonuclease activity;

e) primer extending the riboprimer annealed to the DNA with the strand-displacing DNA polymerase under strand-displacing polymerization conditions;

f) obtaining a double-stranded complex comprising the DNA and a primer extension product, wherein the primer extension product comprises the riboprimer sequence in its 5′

-end portion and the target sequence in its 3′

-end portion;

g) contacting the double-stranded complex with an RNase H enzyme under enzyme reaction conditions so as to release at least a portion of the riboprimer sequence in the 5′

-end portion of the primer extension product of the double-stranded complex;

h) annealing a second riboprimer to the single-stranded DNA of the double-stranded complex, wherein the second riboprimer anneals to the single-stranded DNA at the position where the portion of the riboprimer sequence of the primer extension product was released;

i) primer extending the second riboprimer annealed to the single-stranded DNA of the double-stranded complex with the strand-displacing DNA polymerase under strand-displacing polymerization conditions, so as to displace the first primer extension product from the double-stranded complex and obtain a second double-stranded complex comprising the single-stranded DNA and a second primer extension product; and

j) obtaining the primer extension product that was displaced from the double-stranded complex as a result of extending the second riboprimer annealed to the single-stranded DNA.

22. The method of claim 21, further comprising the step of annealing a blocking oligo to a region of the DNA, wherein the 5′

-end of the blocking oligo that is annealed to the single-stranded DNA delimits the 3′

-end of the target nucleic acid sequence.

23. The method of claim 21, further comprising step k) repeating steps b through j whereby multiple copies of the primer extension products corresponding to the target sequence are produced.

24. The method of claim 21 further comprising step 1) detecting the primer extension products produced.

25. The method of claim 21, further comprising step 1) quantifying the primer extension products.

26. The method of claim 21, wherein a plurality of riboprimers is used.

27. The method of claim 21, wherein the riboprimer comprises only ribonucleotides.

28. The method of claim 21, wherein the 2′

-substituent is selected from the group consisting of a fluorine substituent, an amino substituent, a methoxy substituent, and an azido substituent.

29. The method of claim 21, wherein the riboprimer comprises purine ribonucleotides and pyrimidine 2′

-fluoro-2′

-deoxyribonucleotides.

30. The method of claim 21, wherein the entire sequence of the riboprimer is complementary to the 3′

-end portion of the target sequence.

31. The method of claim 21, wherein the 5′

-end portion of the riboprimer is not complementary to the target nucleic acid sequence.

32. The method of claim 31, wherein the non-complementary 5′

end portion provides a sequence that can be copied by second-strand primer extension using as a template a first-strand cDNA primer extension product made using the riboprimer.

33. The method of claim 31, wherein the target-complementary sequence at the 3′

-end portion of the riboprimer comprises a randomized sequence.

34. The method of claim 22, wherein the blocking oligo comprises a peptide nucleic acid (PNA).

35. The method of claim 21, wherein the DNA polymerase is selected from the group consisting of BST DNA polymerase large fragment (ISOTHERM), SEQUITHERM DNA polymerase (EPICENTRE Technologies), BCABEST DNA polymerase (Takara Shuzo Co.), phi29 DNA polymerase, and Exo-minus Klenow DNA polymerase.

36. The method of claim 21, wherein the RNase H enzyme is a thermostable RNase H.

37. The method of claim 36, wherein said thermostable RNase H is selected from the group consisting of HYBRIDASE thermostable RNase H (EPICENTRE Technologies), Tth RNase H, and Tfl RNase H.

38. The method of claim 21, wherein said RNase H is E. coli RNase H.

39. A method of generating multiple copies of a polynucleotide sequence complementary to an RNA sequence of interest, the method comprising the steps of:

a) extending a first primer hybridized to a target RNA with an RNA-dependent DNA polymerase, wherein the first primer is a riboprimer, wherein said riboprimer comprises;

i) only ribonucleotides, or ii) only purine ribonucleotides and only pyrimidine nucleotides, wherein at least one of the pyrimidine nucleotides is a pyrimidine 2′

-deoxyribonucleotide having a non-canonical substituent, which substituent is neither an H nor an OH, on the 2′

-position of the deoxyribose sugar moiety, and whereby a complex comprising a first primer extension product and the target RNA is produced;

b) cleaving RNA in the complex of step (a) with an RNase H enzyme;

c) extending a second primer hybridized to the first primer extension product with a DNA-dependent DNA polymerase that lacks 5′

-to-3′

exonuclease activity, wherein said second primer is a riboprimer comprising;

i) only ribonucleotides, or ii) only purine ribonucleotides and only pyrimidine nucleotides, wherein at least one of the pyrimidine nucleotides is a pyrimidine 2′

-deoxyribonucleotide having a non-canonical substituent, which substituent is neither an H nor an OH, on the 2′

-position of the deoxyribose sugar moiety, and whereby a second primer extension product is produced to form a complex of first and second primer extension products;

d) cleaving the riboprimer in the complex of first and second primer extension products with an RNase H enzyme such that a riboprimer hybridizes to the second primer extension product; and

e) extending the riboprimer hybridized to the second primer extension product with a DNA-dependent DNA polymerase, whereby the first primer extension product is displaced and multiple copies of a polynucleotide sequence complementary to the RNA sequence of interest are generated.

40. The method of claim 39, wherein the RNA-dependent DNA polymerase is selected from the group consisting of Bst DNA polymerase, BST DNA polymerase large fragment (ISOTHERM), Moloney murine leukemia virus (MMLV) reverse transcriptase, and avian myeloblastosis virus (AMV) reverse transcriptase.

41. The method of claim 40, wherein said MMLV reverse transciptase comprises RNase H minus MMLV reverse transcriptase.

42. The method of claim 39, wherein a plurality of riboprimers is used to generate multiple copies of a polynucleotide sequence complementary to the RNA sequence of interest.

43. The method of claim 39, wherein a plurality of different riboprimers is used for hybridizing to the target RNA.

44. The method of claim 39, wherein the riboprimer comprises only ribonucleotides.

45. The method of claim 39, wherein the 2′

-substituent is selected from the group consisting of a fluorine substituent, an amino substituent, a methoxy substituent, and an azido substituent.

46. The method of claim 39, wherein the riboprimer comprises purine ribonucleotides and pyrimidine 2′

-fluoro-2′

-deoxyribonucleotides.

47. The method of claim 39, wherein the riboprimer comprises AMP, GMP, 2′

-F-dUMP, and 2′

-F-dCMP.

48. The method of claim 39, wherein the riboprimer that hybridizes to the target RNA comprises a poly-U sequence.

49. The method of claim 39, wherein the riboprimer that hybridizes to the target RNA is a random primer.

50. The method of claim 39, wherein the riboprimer that hybridizes to the target RNA comprises a 5′

-portion that is not hybridizable to the target RNA under conditions under which the riboprimer hybridizes to the target RNA.

51. The method of claim 39, wherein the target RNA is mRNA.

52. The method of claim 39, wherein the RNase H enzyme is a thermostable RNase H.

53. The method of claim 52, wherein said thermostable RNase H is selected from the group consisting of HYBRIDASE thermostable RNase H (EPICENTRE Technologies), Tth RNase H, and Tfl RNase H.

54. The method of claim 39, wherein said RNase H is E. coli RNase H.

55. The method of claim 39, wherein the DNA polymerase is selected from the group consisting of BST DNA polymerase large fragment (ISOTHERM), SEQUITHERM DNA polymerase (EPICENTRE Technologies), BCABEST DNA polymerase (Takara Shuzo Co.), phi29 DNA polymerase, and Exo-minus Klenow DNA polymerase.

56. The method of claim 39, wherein the second primer is a random primer.

57. The method of claim 39, wherein the second primer comprises a fragment of the target RNA hybridized to the primer extension product, which fragment is generated by cleaving RNA in the complex in step (b) with an enzyme that cleaves RNA from an RNA/DNA hybrid.

58. The method of claim 39, wherein the second primer comprises DNA.

59. The method of claim 39, wherein the RNA-dependent DNA polymerase and DNA-dependent polymerase are the same enzyme.

60. The method of claim 57 wherein the RNA-dependent DNA polymerase and the enzyme that cleaves RNA from an RNA/DNA hybrid are the same enzyme.

61. The method of claim 39, further comprising the step of:

f) generating multiple copies of a polynucleotide sequence complementary to two or more different sequences of interest.

62. The method of claim 61, wherein at least two different riboprimers that hybridize to the target RNA are used.

63. The method of claim 39, further comprising the step of:

f) attaching the multiple copies onto a solid substrate to make a microarray of the multiple copies.

64. The method of claim 39, further comprising the step of:

f)

hybridizing the multiple copies to a microarray of nucleic acid molecules immobilized on a surface of a solid phase.